1. The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma
   Reiko Isa et al, 2022, International Journal of Molecular Sciences CrossRef
2. LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer
   Yunxiang Zhang et al, 2023, Molecular Cancer CrossRef
3. Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells
   Subehan Lallo et al, 2022, Life CrossRef
4. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma
   Jingsong Shan et al, 2022, Computers in Biology and Medicine CrossRef
5. Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer
   Sisi Qin et al, 2023, International Journal of Molecular Sciences CrossRef
6. Roles of Histone H2A Variants in Cancer Development, Prognosis, and Treatment
   Po Man Lai et al, 2024, International Journal of Molecular Sciences CrossRef
7. Breast Imaging Reporting and Data System evaluation of breast lesions improved with virtual touch tissue imaging average grayscale values
   Weizhen Lian et al, 2024, Technology and Health Care CrossRef
8. Association Between RSK2 and Clinical Indexes of Primary Breast Cancer: A Meta-Analysis Based on mRNA Microarray Data
   Kun Zheng et al, 2021, Frontiers in Genetics CrossRef
9. Intratumor microbiome derived glycolysis-lactate signatures depicts immune heterogeneity in lung adenocarcinoma by integration of microbiomic, transcriptomic, proteomic and single-cell data
   Xiaheng Deng et al, 2023, Frontiers in Microbiology CrossRef